Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Queensland 4059, Australia.
J Biol Chem. 2010 Aug 20;285(34):26162-73. doi: 10.1074/jbc.M109.096453. Epub 2010 Jun 15.
CUB-domain-containing protein 1 (CDCP1) is an integral membrane glycoprotein with potential as a marker and therapeutic target for a number of cancers. Here we examine mechanisms regulating cellular processing of CDCP1. By analyzing cell lines exclusively passaged non-enzymatically and through use of a panel of protease inhibitors, we demonstrate that full-length 135 kDa CDCP1 is post-translationally processed in a range of cell lines by a mechanism involving serine protease activity, generating a C-terminal 70-kDa fragment. Immunopurification and N-terminal sequencing of this cell-retained fragment and detailed mutagenesis, show that proteolytic processing of CDCP1 occurs at two sites, Arg-368 and Lys-369. We show that the serine protease matriptase is an efficient, but not essential, cellular processor of CDCP1 at Arg-368. Importantly, we also demonstrate that proteolysis induces tyrosine phosphorylation of 70-kDa CDCP1 and recruitment of Src and PKCdelta to this fragment. In addition, Western blot and mass spectroscopy analyses show that an N-terminal 65-kDa CDCP1 ectodomain is shed intact from the cell surface. These data provide new insights into mechanisms regulating CDCP1 and suggest that the biological role of this protein and, potentially, its function in cancer, may be mediated by both 70-kDa cell retained and 65-kDa shed fragments, as well as the full-length 135-kDa protein.
CUB 结构域蛋白 1(CDCP1)是一种完整的膜糖蛋白,具有作为多种癌症的标志物和治疗靶点的潜力。在这里,我们研究了调节细胞内 CDCP1 处理的机制。通过分析仅通过非酶途径传代的细胞系和使用蛋白酶抑制剂组合,我们证明在多种细胞系中,全长 135 kDa 的 CDCP1 通过涉及丝氨酸蛋白酶活性的机制进行翻译后加工,产生 C 端 70 kDa 片段。对该细胞保留片段进行免疫纯化和 N 端测序以及详细的诱变分析表明,CDCP1 的蛋白水解加工发生在两个位点,Arg-368 和 Lys-369。我们表明丝氨酸蛋白酶 matriptase 是 CDCP1 在 Arg-368 处的有效但不是必需的细胞处理器。重要的是,我们还证明蛋白水解诱导 70 kDa CDCP1 的酪氨酸磷酸化以及 Src 和 PKCdelta 募集到该片段。此外,Western blot 和质谱分析表明完整的 65 kDa CDCP1 细胞外结构域从细胞表面完整脱落。这些数据提供了有关调节 CDCP1 的机制的新见解,并表明该蛋白的生物学作用及其在癌症中的功能可能由 70 kDa 细胞保留片段和 65 kDa 脱落片段以及全长 135 kDa 蛋白介导。